Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of selenium on endothelial dysfunction in patients with cardiovascular disease (Phase II, 3-arm, randomized, double-blind, single-center trial)
2004-003810-41Phase 2Completed
- Sponsor
- biosyn Corporation
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium selenite in coronary arteriosclerosis (3 arms), sponsored by biosyn Corporation. Primary endpoint: Change in brachial artery flow-mediated dilation. Started May 2005; status: completed.
02
Drugs
sodium selenite
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2004-003810-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003810-41.